Rocket Pharmaceuticals, Inc. - RCKT

SEC FilingsOur RCKT Tweets

About Gravity Analytica

Recent News

  • 05.27.2025 - Update on Phase 2 Clinical Trial of RP-A501 for Danon Disease
  • 05.27.2025 - Rocket Pharmaceuticals Provides Update on Phase 2 Clinical Trial of RP-A501 for Danon Disease

Recent Filings

  • 05.27.2025 - 8-K Current report
  • 05.27.2025 - EX-99.1 EX-99.1
  • 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
  • 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
  • 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
  • 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
  • 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
  • 05.20.2025 - 144 Report of proposed sale of securities
  • 05.20.2025 - 144 Report of proposed sale of securities
  • 05.20.2025 - 4 Statement of changes in beneficial ownership of securities